Statistics on Biotechnology Use Results by fields of operation Company sector. Biotechnology results by main variables and no. of employees. Unidades: specified in variables Fewer than 250 employees 250 or more employees Total 2020 No. of companies carrying out R&D in Biotechnology 1.126 108 1.233 %Companies according to biotechnology used: Genetic code 30,9 40,2 31,7 %Companies according to biotechnology used: Functional units 37,4 50,4 38,5 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 21,6 34,5 22,8 %Companies according to biotechnology used: Bioprocesses 51,7 71 53,4 %Companies according to biotechnology used: Sub-cellular organisms 7,8 16,8 8,6 %Companies according to biotechnology used: Bio-computing 22,2 22,3 22,3 %Companies according to biotechnology used: Nanobiotechnology 10,5 12,1 10,6 %Companies according to biotechnology used: Other 14,7 9,3 14,2 Companies in which biotechnology activities are: Main and/or exclusive 590 25 615 Companies in which biotechnology activities are: A secondary line of business 156 22 178 Companies in which biotechnology activities are: A tool necessary for production 379 61 440 %Company by field(s) of ultimate application of biotechnology use: Human Health 46,2 46,5 46,3 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 16,9 9,3 16,2 %Company by field(s) of ultimate application of biotechnology use: Food products 31,7 35,6 32 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 25,6 14,1 24,6 %Company by field(s) of ultimate application of biotechnology use: Environment 15,3 17,7 15,5 %Company by field(s) of ultimate application of biotechnology use: Industry 13,1 11,1 12,9 Personnel in R&D in biotechnology (no. of persons) 9.325 4.119 13.444 Personnel in R&D in biotechnology (no. of persons): Researchers 5.272 2.106 7.378 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 4.053 2.013 6.066 Personnel in R&D in biotechnology (no. of persons): women 4.869 2.632 7.501 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 2.752 1.299 4.052 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 2.117 1.333 3.450 Personnel in R&D in biotechnology (FTE) 6.291,5 3.110,4 9.401,9 Personnel in R&D in biotechnology (FTE): Researchers 3.811,8 1.586,5 5.398,3 Personnel in R&D in biotechnology (FTE): Technicians and assistants 2.479,7 1.523,9 4.003,6 Personnel in R&D in biotechnology (FTE): women 3.385,8 2.040,5 5.426,2 Personnel in R&D in biotechnology (FTE): (women) Researchers 2.020,5 996 3.016,4 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.365,3 1.044,5 2.409,8 Internal expenditure on R&D (thousands of euros) 586.635 310.698 897.333 1) By nature of the expense: Current expenses 520.977 296.432 817.409 1.1) Remuneration to researchers 182.849 112.856 295.705 1.2) Remuneration to technicians and assistants 90.123 66.730 156.853 1.3) Other current expenses 248.005 116.847 364.852 2) By nature of the expense: Capital expenses 65.658 14.266 79.924 2.1) Land and buildings 6.331 3.941 10.272 2.2) Equipment and instruments 46.970 9.640 56.609 2.3) Acquisition of specific R&D software 4.475 364 4.839 2.4) Otros productos de propiedad intelectual específicos para I+D 7.882 321 8.203 1.1) By origin of the funds: Own funds 406.605 206.492 613.097 1.2) By origin of the funds: From companies 62.831 23.253 86.085 1.3) By origin of the funds: Public Administration funds 71.590 20.550 92.140 1.4) By origin of the funds: From Universities 548 306 853 1.5) By origin of the funds: From non profit private institutions 2.496 2.185 4.682 1.6) By origin of the funds: Foreign funds 42.564 57.912 100.476 Purchase of R&D services in biotechnology (thousands of euros) 48.478 36.533 85.011 Purchase of R&D services in biotechnology (thousands of euros): In Spain 23.128 31.114 54.243 Purchase of R&D services in biotechnology (thousands of euros): Abroad 25.350 5.419 30.768 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 40,9 22,4 39,2 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 11,5 14 11,7 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 12,9 8,4 12,5 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 10,8 11,2 10,9 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 14,7 10,3 14,3 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 17,4 7,5 16,5 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 15,2 13,1 15 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 36 31 36 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 47,2 41 46,7 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 19,3 15,9 19 % Companies that have requested biotechnology patents in Biotechnology 17,3 17,7 17,3 Number of patents requested 600 81 681 % Companies with income of an international origin related to biotechnological activities 23,6 16,8 23 % Turnover representing income of an international origin related to biotechnological activities 5,6 0,9 1,6 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 44,7 69,7 55,9 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 55,3 30,3 44,1 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 97,2 67,6 83,9 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 1,1 31,5 14,7 % Income of an international origin related with activities according to the classification: Operating source abroad 0,7 0,9 0,8 % Income of an international origin related with activities according to the classification: Other 1,1 0 0,6 Notas: '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute